JCRB1092 NCE SVIA6
Cell information
Important Notice(s)Supplements for the Serum free culture medium
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1092 | Cell Name | NCE SVIA6 |
---|---|---|---|
Profile | SV40 transformed human keratinocyte cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | adult |
Identity | available | Tissue for Primary Cancer | cervix |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | teromerase positive SV40 ori(-), p75NTR positive. | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | SV40 transformed keratinocyte cell |
Classify | transformed | Established by | Yasumoto,S. |
Registered by | Yasumoto,S. | Regulation for Distribution | Not applied. |
Comment | Cell line was unique. | Year | 2001 |
Medium | MCDB153 medium (0.03 mM Ca2+) with 5 ug/ml insulin, 0.5 ug/ml hydrocortisone, 10 ug/ml transferrin, 0.1 mM phosphorylethanolamine, 0.1 mM ethanolamine, 10 ng/ml EGF and 40-70 ug/ml bovine pituitary extract. (serum-free) | Methods for Passages | Cells are harvested with 0.1% trypsin and 0.1% EDTA. Medium change every 2 days and subculture every 10 days. |
Cell Number on Passage | 1.5 - 2.4 x 10^5 cells/sq.cm. | Race | Japanese |
CO2 Conc. | Tissue Sampling | cervix | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:12747968 | Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Fujimoto R,Kamata N,Taki M,Yokoyama K,Tomonari M,Nagayama M,Yasumoto S Oral Oncol. 2003 Jul;39(5):445-52 |
Images |
---|
LOT Information
Cell No. | JCRB1092 | Cell Name | |
---|---|---|---|
LOT No. | 10142005 | Lot Specification | distribution |
Medium | MCDB153 medium with 5 ug/ml insulin, 0.5 ug/ml hydrocortisone, 10 ug/ml transferrin, 0.1 mM ethanolamine, 0.1 mM phosphoethanolamine, 10 ng/ml EGF, 70 ug/ml bovine pituitary extract. Serum-free. | Temperature | 37 C |
Cell Density at Seeding | 3 - 7 x 10^4 cells/ml | Methods for Passages | 0.025% trypsin and 0.02% EDTA. Trypsin activity was terminated by soybean trypsin inhibitor after trypsin treatment. |
Doubling Time | approx. 3.5 days | Cell Number in Vial (cells/1ml) | 2.3 x 10^6 |
Viability at cell freezing (%) | 92.8 | Antibiotics Used | free |
Passage Number | P14 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST, LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:10,13 D13S317:11 D7S820:10,13 D16S539:9 VWA:16,17 TH01:7 AM:X TPOX:8,11 CSF1PO:10,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 0.1% methylcellulose - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |